Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07279142Not ApplicableNot Yet Recruiting

Efficacy and Safety of 7 Millimeters Vaginal Radiofrequency in Overactive Bladder

Role: collaborator

NCT06821243Recruiting

Patients with Human Papillomavirus-associated Head and Neck Cancer for the Discovery of Predictive Biomarkers to Guide Clinical Intervention

Role: collaborator

NCT06790381Not Yet Recruiting

Effect of Biological Sex on Multimodal Biomarkers of Disease Progression in Patients with Parkinson's Disease

Role: collaborator

NCT06124989Unknown

Machine learnINg for the rElapse Risk eValuation in Acute Biliary Pancreatitis.

Role: collaborator

All 4 trials loaded